Items without sitelinks
Jump to navigation
Jump to search
Showing below up to 50 results in range #501 to #550.
- thoracic cancer (Q21957)
- lung neoplasm (Q21956)
- respiratory system benign neoplasm (Q21955)
- lung benign neoplasm (Q21954)
- skin neoplasm (Q21953)
- integumentary system neoplasm (Q21952)
- integumentary system benign neoplasm (Q21951)
- skin benign neoplasm (Q21950)
- vitamin D 25-hydroxylase activity (Q21949)
- vitamin D3 25-hydroxylase activity (Q21948)
- calcitriol biosynthetic process from calciol (Q21947)
- vitamin D3 biosynthetic process (Q21946)
- vitamin D3 catabolic process (Q21945)
- vitamin D3 metabolic process (Q21944)
- cholecalciferol (undefined stereochemistry) (Q21943)
- 9,10-secocholestane steroid (Q21942)
- (1S,3Z)-3-[(2E)-2-[(1R,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol (Q21941)
- oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water (Q21938)
- sterol desaturase activity (Q21937)
- delta7-sterol 5(6)-desaturase activity (Q21936)
- 7-dehydrocholesterol reductase activity (Q21935)
- D3 vitamins binding (Q21934)
- D3 vitamins (Q21933)
- phosphorus metabolism disease (Q21931)
- mass concentration (Q21930)
- phosphatemia (Q21929)
- hypophosphatemia (Q21928)
- familial hypophosphatemia (Q21927)
- sterol 3-beta-glucosyltransferase activity (Q21926)
- ergosterol UDP-glucosyltransferase activity (Q21925)
- 5-alpha-hydroxysteroid dehydratase activity (Q21924)
- delta24(24-1) sterol reductase activity (Q21923)
- cellular response to ergosterol (Q21922)
- phytosteroid biosynthetic process (Q21921)
- phytosteroid metabolic process (Q21920)
- ergosterol metabolic process (Q21919)
- cellular lipid biosynthetic process (Q21918)
- cellular alcohol metabolic process (Q21917)
- cellular alcohol biosynthetic process (Q21916)
- ergosterol biosynthetic process (Q21915)
- ergostane steroid (Q21914)
- rickets (Q21912)
- homogeneous organ (Q21911)
- parathyroid (Q21910)
- parathyroid gland disease (Q21909)
- hypoparathyroidism (Q21908)
- vitamin D2 metabolic process (Q21907)
- 9,10-secoergostane steroid (Q21906)
- Radiostol (Q21905)
- Ergocalciferols (Q21904)